AUPH

Aurinia Pharmaceuticals Inc.

Insider Trades

NameValueActionPriceCurrent Price
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
$3.1M206k shares
BuyJun 2, 2026
$15.28
--
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
$5.2M343.5k shares
BuyJun 1, 2026
$15.28
--
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
$1.5k99 shares
BuyJun 1, 2026
$15.34
--
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
$4.0M262.7k shares
BuyMay 29, 2026
$15.31
--
Tang KevinDirector, 10 Percent Owner, Officer: Chief Executive Officer
$35k2.3k shares
BuyMay 29, 2026
$15.35
--
Tang KevinDirector
$2.6M184.2k shares
BuyMar 3, 2026
$14.22
--

News

fool.comAurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Millionfool.comJun 7seekingalpha.comAurinia: Cash-Generating Today, Pipeline-Driven Tomorrowseekingalpha.comJun 4businesswire.comLUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Deathbusinesswire.comJun 4seekingalpha.comAurinia Pharmaceuticals Inc. (AUPH) Shareholder/Analyst Call Prepared Remarks Transcriptseekingalpha.comJun 3feeds.newsfilecorp.comAurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciencesfeeds.newsfilecorp.comMay 19
AUPH smart money exposure | 交易笔记